FENNEC PHARMACEUTICALS INC.
FENCNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for FENC. That does not mean none is planned.
Get an email about FENC's next catalysts
Track FENNEC PHARMACEUTICALS (FENC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
FENC Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $0.09 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Pedmark® STS | Phase 2 | Solid Tumor Malignancies | - | - |
Frequently asked questions
What is in FENNEC PHARMACEUTICALS INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in FENNEC PHARMACEUTICALS INC.'s (FENC) pipeline across Phase 2. Its lead program is Pedmark® STS (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is FENNEC PHARMACEUTICALS INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for FENNEC PHARMACEUTICALS INC. (FENC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track FENC biotech catalysts?→
Add FENC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow FENNEC PHARMACEUTICALS INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.